ORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Orexo is a Swedish pharmaceutical company that develops improved medicines based on proprietary formulation technologies and with a focus on meeting major medical needs. In the US market, Orexo commercializes treatments for patients suffering from opioid addiction. Products targeting other therapeutic areas are developed and commercialized worldwide through partners.
Read moreRevenue M
EBIT-% (adj.)
EPS (adj.)
Dividend %
Extraordinary general meeting '26
Annual report '26
Interim report Q1'27
Don't miss out - create an account and get all the possible benefits